Crossmark

Discontinuation of deep brain stimulation to the medial forebrain bundle leads to depression relapse: considerations when reinstating stimulation

Published Online: 2023-01-16

Published Print: 2023-06

Authors

Fenoy, Albert J. https://orcid.org/0000-0002-9554-9885
Quevedo, Joao

Soares, Jair C. https://orcid.org/0000-0002-5466-5628
License Information

Text and Data Mining valid from 2023-01-16

Version of Record valid from 2023-01-16
More Information

Article History

Received: 28 March 2022

Revised: 5 January 2023

Accepted: 6 January 2023

First Online: 16 January 2023

Competing interests

: AJF serves as a consultant for Medtronic, Inc and receives grant support from the NIH/NINDS (1R01NS113893). JQ receives research support from the NIH/NIMH (1R21MH117636), the Faillace Department of Psychiatry and Behavioral Sciences, and LivaNova; has speaker bureau membership with Myriad Neuroscience, Janssen Pharmaceuticals, and Abbvie; is a consultant for Eurofarma; is stockholder at Instituto de Neurociencias Dr Joao Quevedo; and receives copyrights from Artmed Editora, Artmed Panamericana, and Elsevier/Academic Press. JCS receives grant/research support from Bristol-Meyers Squibb, Forest Laboratories, Merck and Elan Pharmaceuticals, and serves as a consultant for Pfizer, Abbot, and Astellas Pharma, Inc.

Document is current